Clinical Trial Update: Salsalate Therapy to Reduce Insulin Resistance and Cardiovascular Risk [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for salsalate therapy targeting insulin resistance and cardiovascular risk; completed phase 2 and phase 3 with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Cardiovascular Disease
• Inflammation
• Insulin Resistance
• Noninsulin-dependent Diabetes Mellitus

Drugs mentioned

• Salsalate (Salsalate)

Snippet

Sponsor: VA Office of Research and Development | Conditions: Atherosclerosis, Cardiovascular Disease | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2014-04-22